TABLE 4.

Top 20 KEGG pathways ranked by p value.

Pathway	Gene ratio (%)	Count	Log10(P)	Log10(q)
hsa05200:Pathways in cancer	47.89	34	−40.07	−37.53
hsa04933:AGE‐RAGE signalling pathway in diabetic complications	26.76	19	−31.03	−28.79
hsa05417:Lipid and atherosclerosis	28.17	20	−26.13	−24.07
hsa04066:HIF‐1 signalling pathway	21.13	15	−22.18	−20.42
hsa05205:Proteoglycans in cancer	23.94	17	−21.28	−19.58
hsa05215:Prostate cancer	19.72	14	−21.01	−19.43
hsa05152:Tuberculosis	19.72	14	−17.12	−15.86
hsa05144:Malaria	14.08	10	−16.6	−15.4
hsa04218:Cellular senescence	18.31	13	−16.3	−15.17
hsa04068:FoxO signalling pathway	16.9	12	−15.56	−14.5
hsa04064:NF‐kappa B signalling pathway	12.68	9	−11.52	−10.74
hsa05202:Transcriptional misregulation in cancer	12.68	9	−9.11	−8.47
hsa04211:Longevity regulating pathway	9.86	7	−8.76	−8.16
hsa04672:Intestinal immune network for IgA production	8.45	6	−8.76	−8.16
hsa04217:Necroptosis	9.86	7	−7.01	−6.47
hsa04726:Serotonergic synapse	7.04	5	−5.11	−4.64
hsa04611:Platelet activation	7.04	5	−4.95	−4.5
hsa05014:Amyotrophic lateral sclerosis	9.86	7	−4.62	−4.19
hsa04520:Adherens junction	5.63	4	−4.62	−4.19
hsa04610:Complement and coagulation cascades	5.63	4	−4.31	−3.9